Key result
Meloxicam is as effective as nonselective NSAIDs for pain in rheumatic diseases, offering a better safety profile with rare gastrointestinal complications and low cardiovascular risk.
Why the study?
Does meloxicam have a better safety profile and comparable efficacy to nonselective NSAIDs in patients with rheumatic and joint diseases?
Population
Patients with acute and chronic diseases accompanied by pain and inflammation, including rheumatic diseases…
Comparison
Meloxicam vs Nonselective NSAIDs
Design
Review
Authors
Loading...
May support meloxicam preference in high GI-risk patients; leaves open confirmation of CV safety in RCTs.
Does meloxicam have a better safety profile and comparable efficacy to nonselective NSAIDs in patients with rheumatic and joint diseases?
Meloxicam provides effective analgesia and anti-inflammatory effects with a favorable gastrointestinal and cardiovascular safety profile compared to nonselective NSAIDs.
Алексеева et al. (2016) conducted a review in Rheumatic diseases and acute and chronic diseases of the joint and spinal column. Meloxicam vs. Nonselective NSAIDs was evaluated. Meloxicam is as effective as nonselective NSAIDs for pain in rheumatic diseases, offering a better safety profile with rare gastrointestinal complications and low cardiovascular risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: